Vestmark Advisory Solutions’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.99M | Buy |
638,342
+326,460
| +105% | +$3.06M | 0.09% | 173 |
|
|
2025
Q1 | $2.22M | Sell |
311,882
-63,409
| -17% | -$451K | 0.06% | 312 |
|
|
2024
Q4 | $5.41M | Buy |
375,291
+47,045
| +14% | +$678K | 0.19% | 111 |
|
|
2024
Q3 | $6.75M | Sell |
328,246
-27,079
| -8% | -$556K | 0.25% | 81 |
|
|
2024
Q2 | $7.95M | Sell |
355,325
-65,072
| -15% | -$1.46M | 0.33% | 63 |
|
|
2024
Q1 | $11.6M | Buy |
420,397
+154,416
| +58% | +$4.25M | 0.5% | 42 |
|
|
2023
Q4 | $8.11M | Buy |
+265,981
| New | +$8.11M | 0.41% | 53 |
|